Search details
1.
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
Int J Cancer
; 151(11): 1978-1988, 2022 Dec 01.
Article
in English
| MEDLINE | ID: mdl-35833561
2.
Extracellular Vesicle Measurements with Nanoparticle Tracking Analysis: A Different Appreciation of Up and Down Secretion.
Int J Mol Sci
; 23(4)2022 Feb 19.
Article
in English
| MEDLINE | ID: mdl-35216426
3.
Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
BMC Cancer
; 21(1): 1313, 2021 Dec 07.
Article
in English
| MEDLINE | ID: mdl-34876055
4.
[ACACIAS 3: Learning about announcement consultations in the second cycle of medical studies]. / ACACIAS 3 : Apprentissage des consultations d'annonce dans le deuxième cycle d'études médicales.
Bull Cancer
; 111(2): 153-163, 2024 Feb.
Article
in French
| MEDLINE | ID: mdl-38042749
5.
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital.
Front Oncol
; 13: 1104659, 2023.
Article
in English
| MEDLINE | ID: mdl-36923436
6.
Quality of Life of Patients With Cancer During the COVID-19 Pandemic.
In Vivo
; 35(1): 663-670, 2021.
Article
in English
| MEDLINE | ID: mdl-33402524
7.
Impact of Body Composition in Overweight and Obese Patients With Localised Renal Cell Carcinoma.
In Vivo
; 34(5): 2873-2881, 2020.
Article
in English
| MEDLINE | ID: mdl-32871827
8.
Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme).
Med Oncol
; 37(8): 69, 2020 Jul 25.
Article
in English
| MEDLINE | ID: mdl-32712771
Results
1 -
8
de 8
1
Next >
>>